Detalhes bibliográficos
| Ano de defesa: |
2023 |
| Autor(a) principal: |
Letícia Lemes de Souza |
| Orientador(a): |
Davi Campos La Gatta |
| Banca de defesa: |
Não Informado pela instituição |
| Tipo de documento: |
Dissertação
|
| Tipo de acesso: |
Acesso aberto |
| Idioma: |
por |
| Instituição de defesa: |
Fundação Universidade Federal de Mato Grosso do Sul
|
| Programa de Pós-Graduação: |
Não Informado pela instituição
|
| Departamento: |
Não Informado pela instituição
|
| País: |
Brasil
|
| Palavras-chave em Português: |
|
| Link de acesso: |
https://repositorio.ufms.br/handle/123456789/8400
|
Resumo: |
Introduction: The addiction is a chronic disease that has become a global public health problem. It is characterized by the compulsive search and consumption of psychoactive substances that lead to personal and professional losses. According to the World Drug Report, 5.5% of the population uses drugs, but only 1 out of 7 individuals receives adequate care. The treatment of addiction aims to alleviate the “craving”, control the symptoms of the withdrawal syndrome and avoid relapses, and the pharmacological treatment is complex and non-specific, in addition, patients have low adherence. Pharmacotherapeutic monitoring has been shown to be effective in improving the quality of life of patients with other chronic diseases, and the pharmacist is the reference professional to identify problems related to medications, drug interactions and other problems related to pharmacological therapy for these patients. Objective: To carry out pharmacotherapeutic monitoring of patients admitted to the Psychosocial Care Center for Alcohol and Drugs IV in the city of Campo Grande – MS. Methodology: Analysis of medical records and interviews were carried out with addicted patients who were admitted to a Psychosocial Care Center for Alcohol and Drugs IV in the city of Campo Grande – MS, from May 2022 to April 2023. An instrument was used for pharmaceutical monitoring. Drug interactions were identified by using Drugs.com website. Problems related to medications were also identified and classified and, when necessary, interventions were made and their acceptability recorded. Results: Among the 52 patients admitted to the study, 92% were men, black and mixed race (73.1%), with an average age of 37 years, minimum age of 18 years and a maximum age of 62 years. 63.4 % were single, unemployed (61.5%), multiple drugs users, who declared that they had incomplete primary education (42.3%), monthly income of up to 1 minimum wage (44.2%) and it was common for patients to have illnesses previous mental illness (42.3%). 929 medications were prescribed. Patients had a polypharmacy pattern, with an average of 5.4 medications per prescription. The maximum number of medications prescribed was 12 and the minimum was 2. The most prescribed medication was Diazepam. Despite having found 449 drug related problemas (DRPs) and 2,636 pharmacological interactions (PIs), the levels of acceptability of pharmaceutical interventions were low. The main medication error was therapeutic duplication and 452 intentional discrepancies related to omitted doses or drugs were recorded. Conclusion: Pharmaceutical interventions can contribute to the rational use of medicines, avoid medication errors as well as possible problems caused by pharmacotherapy when there is collaboration between professionals involved in patient care. However, there is still resistance to the acceptance of pharmaceutical interventions, making it necessary to disseminate the work of clinical pharmacists. Keywords: Addiction, public health, medication-related problems, drug interactions and clinical pharmacy. |
